Skip to main content
. 2017 Aug 21;23(31):5746–5754. doi: 10.3748/wjg.v23.i31.5746

Table 1.

Demographic and clinical characteristics of chronic hepatitis B patients n (%)

Characteristic PNALT (n = 95) PIALT1 (n = 86) PIALT2 (n = 64) Statistic P value
Age (yr) 34.5 ± 11.2 34.2 ± 12.5 36.5 ± 13.5 5.423 0.0211
Sex
Male 70 (73.7) 58 (67.4) 46 (71.9) 0.885 0.6422
Female 25 (26.3) 28 (32.6) 18 (28.1)
BMI 23.4 ± 2.65 24.0 ± 3.6 24.25 ± 3.37 1.231 0.5431
PLT (× 109/L) 200.1 ± 60.3 196.8 ± 65.4 186.5 ± 74.5 6.364 0.0181
PTA (%) 99.6 ± 6.7 99.6 ± 8.7 102.3 ± 10.3 0.674 0.7741
ALB (g/L) 41.3 ± 3.4 41.6 ± 3.7 42.4 ± 4.1 1.536 0.5431
ALT (U/L) 21.4 ± 4.3 56.2 ± 19.4 113.6 ± 55.3 25.754 < 0.0011
AST (U/L) 22.6 ±6.8 55.4 ± 16.6 124.5 ± 57.6 31.644 < 0.0011
APRI 0.32 ± 0.14 0.61 ± 0.44 1.25 ± 0.62 284.92 < 0.0011
FIB-4 0.72 ± 0.36 1.12 ± 0.53 1.67 ± 0.84 56.37 < 0.0011
FibroScan (kPa) 5.33± 2.45 7.36 ± 3.14 10.22 ± 5.53 46.34 < 0.0011
HBsAg [lg (IU/L)] 4.41 ± 0.73 4.53 ± 0.88 4.38 ± 0.64 0.743 0.437
HBV DNA [lg (IU/mL)] 6.78 ± 2.13 6.53 ± 2.43 6.42 ± 2.54 0.864 0.2541
≥ 3, < 5 15 (15.8) 11 (12.8) 10 (15.6) 0.384 0.8252
≥ 5 80 (84.2) 75 (87.2) 54 (84.4)
E antigen
Positive 42 (44.2) 31 (36) 29 (45.3) 1.78 0.4112
Negative 53 (55.8) 55 (64) 35 (54.7)
Necroinflammatory score 2.21 ± 2.14 3.47 ± 3.64 4.74 ± 3.65 23.43 0.001
Minimal 35 (32.4) 20 (23.3) 8 (12.5) 18.69 0.005
Mild 44 (38) 38 (44.2) 27 (42.4)
Moderate 15 (15.8) 26 (30.2) 22 (34.4)
Severe 1 (0.9) 2 (2.3) 7 (10.9)
Fibrosis score 1.53 ± 0.46 2.38 ± 1.27 2.85 ± 1.75 15.237 0.0051
Minimal 32 (33.7) 18 (20.9) 13 (20.3) 13.275 0.0352
Mild 40 (42.1) 40 (51.2) 23 (35.9)
Moderate 21 (22.1) 24 (27.9) 21 (32.8)
Severe 2 (2.1) 5 (5.8) 7 (10.9)
1

One-way analysis of variance;

2

Pearson χ2. APRI = [AST (U/L)/ULN × 100/PLT (109/L)]; FIB-4 = [age (yr) × AST (U/L)]/[PLT (109/L) × (ALT U/L)1/2].